Journal article

Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex

  • Macagno, Annalisa Institute for Research in Biomedicine (IRB), Faculty of Biomedical Sciences, Università della Svizzera italiana, Switzerland
  • Bernasconi, Nadia L. Institute for Research in Biomedicine (IRB), Faculty of Biomedical Sciences, Università della Svizzera italiana, Switzerland
  • Vanzetta, Fabrizia Institute for Research in Biomedicine (IRB), Faculty of Biomedical Sciences, Università della Svizzera italiana, Switzerland
  • Dander, Erica Institute for Research in Biomedicine (IRB), Faculty of Biomedical Sciences, Università della Svizzera italiana, Switzerland
  • Sarasini, Antonella Servizio di Virologia, Fondazione IRCCS Policlinico San Matteo, I-27100 Pavia, Italy
  • Revello, Maria Grazia Servizio di Virologia, Fondazione IRCCS Policlinico San Matteo, I-27100 Pavia, Italy
  • Gerna, Giuseppe Servizio di Virologia, Fondazione IRCCS Policlinico San Matteo, I-27100 Pavia, Italy
  • Sallusto, Federica Institute for Research in Biomedicine (IRB), Faculty of Biomedical Sciences, Università della Svizzera italiana, Switzerland
  • Lanzavecchia, Antonio Institute for Research in Biomedicine (IRB), Faculty of Biomedical Sciences, Università della Svizzera italiana, Switzerland
Show more…
    22.12.2009
Published in:
  • Journal of Virology. - 2010, vol. 84, no. 2, p. 1005-1013
English Human cytomegalovirus (HCMV) is a widely circulating pathogen that causes severe disease in immunocompromised patients and infected fetuses. By immortalizing memory B cells from HCMV-immune donors, we isolated a panel of human monoclonal antibodies that neutralized at extremely low concentrations (90% inhibitory concentration [IC90] values ranging from 5 to 200 pM) HCMV infection of endothelial, epithelial, and myeloid cells. With the single exception of an antibody that bound to a conserved epitope in the UL128 gene product, all other antibodies bound to conformational epitopes that required expression of two or more proteins of the gH/gL/UL128-131A complex. Antibodies against gB, gH, or gM/gN were also isolated and, albeit less potent, were able to neutralize infection of both endothelial-epithelial cells and fibroblasts. This study describes unusually potent neutralizing antibodies against HCMV that might be used for passive immunotherapy and identifies, through the use of such antibodies, novel antigenic targets in HCMV for the design of immunogens capable of eliciting previously unknown neutralizing antibody responses.
Language
  • English
Classification
Medicine
License
License undefined
Identifiers
  • RERO DOC 324216
Persistent URL
https://susi.usi.ch/usi/documents/318965
Statistics

Document views: 6 File downloads:
  • Macagno_JV_2010.pdf: 1